Avidity Partners Management LP Sarepta Therapeutics, Inc. Transaction History

Avidity Partners Management LP

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 14, 2023	BUY	$102.5 - $123.59 $15.6 Million - $18.8 Million	152,500 Added 51.26%	450,000 $54.5 Million
Q2 2023 Aug 14, 2023	SELL	$106.4 - $157.19 $12.6 Million - $18.6 Million	-118,500 Reduced 28.49%	297,500 $34.1 Million
Q1 2023 May 15, 2023	SELL	$117.53 - $155.99 $75.1 Million - $99.7 Million	-639,000 Reduced 60.57%	416,000 $57.3 Million
Q4 2022 Feb 14, 2023	BUY	$100.86 - $132.13 $10.8 Million - $14.1 Million	106,800 Added 11.26%	1,055,000 $137 Million
Q3 2022 Nov 14, 2022	BUY	$75.71 - $119.24 $71.8 Million - $113 Million	948,200 New	948,200 $105 Million
Q1 2021 May 17, 2021	SELL	$72.25 - $168.95 $15.7 Million - $36.7 Million	-217,400 Closed	0 $0
Q4 2020 Feb 16, 2021	BUY	$125.56 - $178.74 $27.3 Million - $38.9 Million	217,400 New	217,400 $37.1 Million
Q2 2020 Aug 14, 2020	SELL	$93.0 - $171.7 $7.44 Million - $13.7 Million	-80,000 Closed	0 $0
Q1 2020 Jun 17, 2020	BUY	$82.38 - $131.64 $6.59 Million - $10.5 Million	80,000 New	80,000 $7.83 Million

529

84.2M

2.06M

1.52M

Ticker SRPT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 87,567,904
Market Cap $10.4B
Description
Sarepta Therapeutics, Inc., a commercial-stage biopharmaceutical company, focuses on the discovery and development of RNA-targeted therapeutics, gene therapies, and other genetic therapeutic modalities for the treatment of rare diseases. It offers EXONDYS 51 injection to treat duchenne muscular dystrophy (duchenne) in patients with confirmed mut...

Get notified when there are updates to the investment portfolio of Avidity Partners Management LP, based on Form 13F filings with the SEC.

Stay updated on Avidity Partners Management LP with notifications on news.